Key Neurology Devices Market Players:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
international neurology devices market is effectively dominated by the presence of organizations, such as Boston Scientific, Abbott, and Medtronic, collectively accounting for 65% of the overall market share. This is effectively propelled by AI-powered advancements, along with tactical acquisitions. Besides, firms in Europe, including Siemens Healthineers, have focused on neuroimaging, while companies from Japan, such as Omron and Nihon Kohden, deliberately dominate the APAC region with the existence of affordable diagnostics. Meanwhile, China-based firms, including MicroPort, have challenged incumbents with a USD 550 million investment for research and development, particularly catering to neurovascular technology, thus suitable for proliferating the market globally.
Here is a list of key players operating in the global market:
| Company Name | Compan | Market Share (2024) | Industry Focus |
|
Medtronic |
U.S. |
22.6% |
Leader in DBS (Percept PC), spinal cord stimulators, and AI-enabled neurodiagnostics |
|
Abbott Laboratories |
U.S. |
18.5% |
Neurostimulators (Proclaim SCS), stroke intervention devices |
|
Boston Scientific |
U.S. |
15.3% |
Vercise DBS systems, embolization coils for aneurysms |
|
Siemens Healthineers |
Germany |
10.2% |
Advanced MRI/EEG systems, robotic neurosurgery tools |
|
Stryker |
U.S. |
8.7% |
Neurovascular devices (Trevo stent retrievers) |
|
Johnson & Johnson (Cerenovus) |
U.S. |
xx% |
Stroke thrombectomy devices, neurovascular stents |
|
GE Healthcare |
U.S. |
xx% |
Portable EEGs, AI-based neuroimaging solutions |
|
LivaNova |
UK |
xx% |
Vagus nerve stimulators for epilepsy |
|
Penumbra |
U.S. |
xx% |
Neurothrombectomy systems (Jet 7) |
|
Integra LifeSciences |
U.S. |
xx% |
Neurosurgical tools, CSF management devices |
|
MicroPort Scientific |
China |
xx% |
Neurointerventional devices (APOLLO stent) |
|
Nevro |
U.S. |
xx% |
HFX spinal cord stimulation for chronic pain |
|
Natus Medical |
U.S. |
xx% |
Neonatal EEG, neurodiagnostic equipment |
|
Brainlab |
Germany |
xx% |
Neurosurgical navigation systems, AI-driven planning software |
|
Cadwell Industries |
U.S. |
xx% |
Portable neuromonitoring devices |
Sources: FDA, SEC, Boston Scientific, Siemens-Healthineers, Stryker, JNJ, GE Healthcare, Liva Nova, Penumbra Inc., Integra-LS, MicroPort, Nevro, Natus, Brainlab, Cadwell, Nihon Kohden, Omron Healthcare, Terumo Corporation, Fukuda Denshi, Mizuho Medical
Below are the areas covered for each company in the market: